Christopher Bolich, DO
Hospice and Palliative Medicine · Camden, NJNPI 1861592347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations.
Across 36 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$66
- Foundation Medicine, Inc.$60
- Bayer$52
- Pharmacosmos Therapeutics Inc.$38
- Takeda Pharmaceuticals U.S.A., Inc.$35
- Novartis$31
- plus $300 from 16 others
What the payments were for
- Food & beverage$583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $66 |
| Foundation Medicine, Inc. | 4 | $60 |
| Bayer | 3 | $52 |
| Pharmacosmos Therapeutics Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Novartis | 2 | $31 |
| Seagen Inc. | 2 | $30 |
| Tempus AI, Inc | 2 | $28 |
| Genmab U.S., Inc. | 2 | $27 |
| Abbott | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $17 |
| Novocure Inc. | 1 | $16 |
| GE HealthCare | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Morphosys, US Inc. | 1 | $14 |
| Sobi, Inc | 1 | $13 |
| Incyte Corporation | 1 | $13 |
How this compares
$583 in reported general payments places this provider in the 80th percentile of 38 hospice and palliative medicine providers in New Jersey.
See all hospice and palliative medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $18,986 |
| Buprenorphine | 20 | $4,988 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 11 | $3,332 |
| Oxycodone Hcl | 154 | $3,208 |
| Naloxone Hcl | 50 | $2,919 |
| Divalproex Sodium | 11 | $1,693 |
| Atorvastatin Calcium | 75 | $1,161 |
| Morphine Sulfate ErMorphine Sulfate | 34 | $1,137 |
| Gabapentin | 100 | $1,111 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 17 | $986 |
| Nebivolol Hcl | 12 | $873 |
| Duloxetine Hcl | 65 | $855 |
| Escitalopram Oxalate | 40 | $774 |
| Pregabalin | 39 | $587 |
| Mirtazapine | 16 | $461 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Camden
- Rania LoutfiCamden$12
- Stacey Rifkin-ZenenbergHackensack$19K
- Kenneth AdessaParsippany$16K
- Ramy SedhomPlainsboro$3K
- Anjali DesaiMorristown$3K
- Keith PasichowLong Branch$834
- Ilene LauferWest New York$666
- Vandana SharmaNeptune$653
- Maria ShindlerMorristown$514
- Felix PachecoParamus$408
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.